Amyloid-specific fluorophores for the rapid, sensitive in situ detection of prion contamination on surgical instruments

Journal of General Virology

Volumn 88, Issue 9, 2007, Pages 2619-2626

  Lipscomb, I P ^a   Herve R ^a   Harris, K ^a   Pinchin, H ^a   Colin, R ^a   Keevil, C W ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; PRION PROTEIN; STAINLESS STEEL; THIAZOLE; THIOFLAVINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; EPIFLUORESCENCE MICROSCOPY; FEMALE; FLUORESCENCE ANALYSIS; IATROGENIC DISEASE; MICROBIAL CONTAMINATION; MOUSE; NONHUMAN; PRION; PRIORITY JOURNAL; PROTEIN ANALYSIS; RISK REDUCTION; SENSITIVITY ANALYSIS; SMEAR; SPLEEN; SURGICAL INSTRUMENT; TISSUE HOMOGENATE; TISSUE SECTION;

BRAIN; EQUIPMENT CONTAMINATION; FLUORESCENT DYES; HUMANS; INDICATORS AND REAGENTS; PRIONS; PRPSC PROTEINS; SENSITIVITY AND SPECIFICITY; STAINLESS STEEL; SURGICAL INSTRUMENTS;

EID: 34548202342     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.82228-0     Document Type: Article

References (54)

1. ACDP/SEAC (2003). Transmissible Spongiform Encephalopathy Agents: Safe Working and the Prevention of Infection. London: The Stationery Office. http://www.advisorybodies.doh.gov.uk/acdp/tseguidance/ Index.htm
2. Appel, T., Wolff, M., von Rheinbaben, F., Heinzel, M. & Riesner, D. (2001). Heat stability of prion rods and recombinant prion protein in water, lipid and lipid-water mixtures. J Gen Virol 82, 465-473.
3. Bancroft, J. D. & Stevens, A. (1990). Theory and Practice of Histological Techniques, 3rd edition. Edinburgh: Churchill Livingstone.
4. Bell, J. E., Gentleman, S. M., Ironside, J. W., McCardle, L., Lantos, P. L., Doey, L., Lowe, J., Fergusson, J., Luthert, P. & other authors (1997). Prion. protein immunocytochemistry - UK five centre consensus report. Neuropathol Appl Neurobiol 23, 26-35.
5. Bernoulli, C., Siegfried, J., Baumgartner, G., Regli, F., Rabinowicz, T., Gajdusek, D. C. & Gibbs, C. J., Jr (1977). Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery. Lancet 1, 478-479.
6. Betmouni, S. & Perry, V. H. (1999). The acute inflammatory response in CNS following injection of prion brain homogenate or normal brain homogenate. Neuropathol Appl Neurobiol 25, 20-28.
7. Bosque, P. J., Ryou, C., Telling, G., Peretz, D., Legname, G., DeArmond, S. J. & Prusiner, S. B. (2002). Prions in skeletal muscle. Proc Natl Acad Sci U S A 99, 3812-3817.
8. Brown, K. L., Ritchie, D. L., McBride, P. A. & Bruce, M. E. (2000). Detection of PrP in extraneural tissues. Microsc Res Tech 50, 40-45.
9. Bruce, M. E., Dickinson, A. G. & Fraser, H. (1976). Cerebral amyloidosis in scrapie in the mouse: effect of agent strain and mouse genotype. Neuropathol Appl Neurobiol 2, 471-478.
10. Burns, J., Pennock, C. A. & Stoward, P. J. (1967). The specificity of the staining of amyloid deposits with thioflavine T. J Pathol Bacteriol 94, 337-344.
11. Collins, S. & Masters, C. L. (1996). Iatrogenic and zoonotic Creutzfeldt-Jakob disease: the Australian perspective. Med J Aust 164, 598-602.
12. Cooley, W. A., Clark, J. K., Ryder, S. J., Davis, L. A., Farrelly, S. S. & Stack, M. J. (2001). Evaluation of a rapid Western immunoblotting procedure for the diagnosis of bovine spongiform encephalopathy (BSE) in the UK. J Comp Pathol 125, 64-70.
13. Davis, J. M. & Himwich, W. A. (1973). Amino acids and proteins of developing mammalian brain. In Biochemistry of the Developing Brain, p. 102. Edited by W. A. Himwich. New York: Marcel Dekker.
14. Dell'Omo, G., Vannoni, E., Vyssotski, A. L., Di Bari, M. A., Nonno, R., Agrimi, U. & Lipp, H. P. (2002). Early behavioural changes in mice infected with BSE and scrapie: automated home cage monitoring reveals prion strain differences. Eur J Neurosci 16, 735-742.
15. Folch Pi, J. (1955). In Biochemistry and the Developing Nervous System, pp. 121-133. Edited by H. Waelsch. New York. Academic Press.
16. Franklin, K. & Paxinos, G. (1997). The Mouse Brain in Stereotaxic Coordinates. San Diego, London: Academic Press.
17. Guntern, R., Bouras, C., Hof, P. R. & Vallet, P. G. (1992). An improved thioflavine S method for staining neurofibrillary tangles and senile plaques in Alzheimer's disease. Experientia 48, 8-10.
18. Hachiya, N. S., Imagawa, M. & Kaneko, K. (2007). The possible role of protein X, a putative auxiliary factor in pathological prion replication, in regulating a physiological endoproteolytic cleavage of cellular prion protein. Med Hypotheses 68, 670-673.
19. Hilton, D. A., Ghani, A. C., Conyers, L., Edwards, P., McCardle, L., Ritchie, D., Penney, M., Hegazy, D. & Ironside, J. W. (2004). Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol 203, 733-739.
20. Hunter, N., Foster, J., Chong, A., McCutcheon, S., Parnham, D., Eaton, S., MacKenzie, C. & Houston, F. (2002). Transmission of prion diseases by blood transfusion. J Gen Virol 83, 2897-2905.
21. Ironside, J. W. (2006). Variant Creutzfeldt-Jakob disease: risk of transmission by blood transfusion and blood therapies. Haemophilia 12 (Suppl. 1), 8-15.
22. Ishikawa, K., Doh-ura, K., Kudo, Y., Nishida, N., Murakami-Kubo, I., Ando, Y., Sawada, T. & Iwaki, T. (2004). Amyloid imaging probes are useful for detection of prion plaques and treatment of transmissible spongiform encephalopathies. J Gen Virol 85, 1785-1790.
23. Kascsak, R. J., Rubenstein, R., Merz, P. A., Tonna-DeMasi, M., Fersko, R., Carp, R. I., Wisniewski, H. M. & Diringer, H. (1987). Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J Virol 61, 3688-3693.
24. Keevil, C. W. (2003). Rapid detection of biofilms and adherent pathogens using scanning confocal microscopy and episcopic differential interference contrast microscopy. Water Sci Technol 47, 105-116.
25. Klunk, W. E., Wang, Y., Huang, G. F., Debnath, M. L., Holt, D. P. & Mathis, C. A. (2001). Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain. Life Sci 69, 1471-1484.
26. Kovacs, G. G., Head, M. W., Hegyi, I., Bunn, T. J., Flicker, H., Hainfellner, J. A., McCardle, L., Laszlo, L., Jarius, C. & other authors (2002). Immunohistochemistry for the prion protein: comparison of different monoclonal antibodies in human prion disease subtypes. Brain Pathol 12, 1-11.
27. Lee, D. C., Stenland, C. J., Miller, J. L., Cai, K., Ford, E. K., Gilligan, K. J., Hartwell, R. C., Terry, J. C., Rubenstein, R. & other authors (2001). A direct relationship between the partitioning of the pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the purification of plasma proteins. Transfusion 41, 449-455.
28. Lipscomb, I. P., Pinchin, H. E., Collin, R., Harris, K. & Keevil, C. W. (2006a). The sensitivity of approved ninhydrin and Biuret tests in the assessment of protein contamination on surgical steel as an aid to prevent iatrogenic prion transmission. J Hosp Infect 64, 288-292.
29. Lipscomb, I. P., Sihota, A. K., Botham, M., Harris, K. L. & Keevil, C. W. (2006b). Rapid method for the sensitive detection of protein contamination on surgical instruments. J Hosp Infect 62, 141-148.
30. Lipscomb, I. P., Sihota, A. K. & Keevil, C. W. (2006c). Comparative study of surgical instruments from sterile-service departments for presence of residual gram-negative endotoxin and proteinaceous deposits. J Clin Microbiol 44, 3728-3733.
31. Lipscomb, I. P., Sihota, A. K. & Keevil, C. W. (2006d). Diathermy forceps and pencils: reservoirs for protein and prion contamination? J Hosp Infect 64, 193-194.
32. Liu, W. G., Brown, D. A. & Fraser, J. R. (2003). Immunohistochemical comparison of anti-prion protein (PrP) antibodies in the CNS of mice infected with scrapie. J Histochem Cytochem 51, 1065-1071.
33. Llewelyn, C. A., Hewitt, P. E., Knight, R. S., Amar, K., Cousens, S., Mackenzie, J. & Will, R. G. (2004). Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 363, 417-421.
34. Lockhart, A., Ye, L., Judd, D. B., Merritt, A. T., Lowe, P. N., Morgenstern, J. L., Hong, G., Gee, A. D. & Brown, J. (2005). Evidence for the presence of three distinct binding sites for the thioflavin T class of Alzheimer's disease PET imaging agents on β-amyloid peptide fibrils. J Biol Chem 280, 7677-7684.
35. McBride, P. A., Bruce, M. E. & Fraser, H. (1988). Immunostaining of scrapie cerebral amyloid plaques with antisera raised to scrapie-associated fibrils (SAF). Neuropathol Appl Neurobiol 14, 325-336.
36. Meyer-Luehmann, M., Coomaraswamy, J., Bolmont T., Kaeser, S., Schaefer, C., Kilger, E., Neuenschwander, A., Abramowski, D., Frey, P. & other authors (2006). Exogenous induction of cerebral β-amyloidogenesis is governed by agent and host. Science 313, 1781-1784.
37. Mouse Brain Library (2002). http://www.mbl.org/
38. NHS Estates (1997). Washer-Disinfectors: Validation and Verification. Health Technical Memorandum 2030. Edited by NHS Estates. London: The Stationery Office. http://195.92.246.148/ knowledge_network/documents/ HTM2030%20Washer-disinfectors%20Operational%20management% 202003123145743890.pdf
39. Sc aggregates. J Virol 79, 12355-12364.
40. Pauli, G. (2005). Tissue safety in view of CJD and variant CJD. Cell Tissue Bank 6, 191-200.
41. Peden, A. H., Head, M. W., Ritchie, D. L., Bell, J. E. & Ironside, J. W. (2004). Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 364, 527-529.
42. Sc in the skeletal muscle of patients with variant, iatrogenic, and sporadic forms of Creutzfeldt-Jakob disease. Am J Pathol 168, 927-935.
43. Prusiner, S. B. (1998). The prion diseases. Brain Pathol 8, 499-513.
44. Riek, R. (2006). Cell biology: infectious Alzheimer's disease? Nature 444, 429-431.
45. Ritchie, D. L., Head, M. W. & Ironside, J. W. (2004). Advances in the detection of prion protein in peripheral tissues of variant Creutzfeldt-Jakob disease patients using paraffin-embedded tissue blotting. Neuropathol Appl Neurobiol 30, 360-368.
46. Saeed, S. M. & Fine, G. (1967). Thioflavin-T for amyloid detection. Am J Clin Pathol 47, 588-593.
47. SCENIHR (2005). The Safety of Human-Derived Products with Regard to Variant Creutzfeldt-Jakob Disease. Edited by the European Commission. http://ec.europa.eu/health/ph_risk/committees/ 04_scenihr/docs/scenihr_o_004.pdf
48. Spongiform Encephalopathy Advisory Committee (2005). Minutes of the open session of the 86th meeting. http://www.seac.gov.uk/minutes/ final86.pdf
49. Surewicz, W. K., Jones, E. M. & Apetri, A. C. (2006). The emerging principles of mammalian prion propagation and transmissibility barriers: insight from studies in vitro. Acc Chem Res 39, 654-662.
50. UK CJD Surveillance Unit (2006). Creutzfeldt-Jakob disease surveillance in the UK. Fourteenth annual report. http://www.cjd.ed.ac.uk/report14.pdf
51. Wadsworth, J. D., Joiner, S., Hill, A. F., Campbell, T. A., Desbruslais, M., Luthert, P. J. & Collinge, J. (2001). Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet 358, 171-180.
52. Weissmann, C., Enari, M., Klohn, P. C., Rossi, D. & Flechsig, E. (2002). Transmission of prions. Proc Natl Acad Sci U S A 99 (Suppl. 4), 16378-16383.
53. Will, R. G., Ironside, J. W., Zeidler, M., Cousens, S. N., Estibeiro, K., Alperovitch, A., Poser, S., Pocchiari, M., Hofman, A. & Smith, P. G. (1996). A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347, 921-925.
54. Zobeley, E., Flechsig, E., Cozzio, A., Enari, M. & Weissmann, C. (1999). Infectivity of scrapie prions bound to a stainless steel surface. Mol Med 5, 240-243.